This website is for information purposes only. Use of our website is subject to your agreement to our disclaimer and terms and conditions. By closing (click "I agree") or leaving this box, you signify your agreement to these.
To repair and boost the immune system by promoting the production of new immuno-competent cells by the bone marrow via the immune cell stimulant IL-7, especially when it has been damaged by cancer treatments such as chemotherapy or radiotherapy, it is vital to promote the activity of IL7 gene. The SSHD-IL7 molecule targets IL7 gene for stimulating the production of immune cells.
What does IL-7 do?
Anti-cancer treatments such as chemotherapy and radiotherapy that are used to kill cancer cells also damage cells in the bone marrow that make new immuno-competent cells. That is one of the reasons why many cancer patients develop an increased susceptibility to infections.
IL-7 is a natural cytokine that has the ability to stimulate the production of new immuno-competent cells in the bone marrow to help compensate for the immune deficiency caused by cancer treatments [1]. Therefore, SSHd-IL7 molecule has been designed to help repair damaged immune systems in cancer patients. It may also be of help to boost the production of new immune cells in those that suffer generalised immune deficiency perhaps as a consequence of infection by the AIDS virus [2]. It is also helpful for increasing the benefits of immunisation.